FDC’s manufacturing facility for Active Pharmaceutical Ingredients (API’s) located at Roha in state of Maharashtra, was recently inspected by US Food and Drug Administration (USFDA). It has successfully cleared the USFDA GMP inspection with ‘No observation’.
This was the 12th consecutive successful USFDA inspection of this facility. The Active Pharmaceutical Ingredients (API’s) manufactured at the above facility continues to be exported to USA.
FDC is engaged in manufacture of specialized formulations, and oral rehydration salts (ORS).
